Disclaimer
The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.
Podcast with Ian Crosbie – 21/01/2022
“Water, Water, Everywhere – Innovations in Treating Diuretic Resistant Fluid Overload” featuring Ian Crosbie
Bolero Biotech event – October 2021
Bolero Biotech Event featuring Ian Crosbie, CEO Sequana Medical – timeslot 00:43:12 – 01:21:27
Edison TV – 28/07/2021
Sequana Medical – executive interview
Kanaal Z – 04/02/2021
Sequana Medical opent deur naar behandeling hartaandoeningen
Kanaal Z – 23/01/2020
Sequana haalt forst kapitaal op, aan forse korting ook
Kanaal Z – 15 /10/2018
Zwitsers medtechbedrijf Sequana kiest voor Gent
